美国老年医保患者术后神经认知障碍的经济负担
该回顾性队列研究利用2013年1月至2016年12月4285家医院提交的医保按服务付费索赔数据,纳入2380473例65岁及以上接受住院手术、既往无术后神经认知障碍且未透析或同时参加医疗补助的医保患者。术后神经认知障碍定义为出院后1年内诊断谵妄、轻度认知障碍或痴呆,共44974例(1.9%)被诊断。与非术后神经认知障碍患者相比,术后神经认知障碍患者住院时间更长(5.91天 vs 4.29天)、出院回家比例更低(22.1% vs 39.2%)、1年死亡率更高(10.2% vs 4.4%),校正患者与医院特征后1年内费用增加17275美元(95%CI 17058-17491美元)。作者认为术后神经认知障碍是风险干预和价值医疗的潜在靶点。
要点
- 2380473例65岁及以上老年医保手术患者中44974例(1.9%)在术后1年内被诊断术后神经认知障碍。
- 术后神经认知障碍患者1年费用较无诊断者增加17275美元(95%CI 17058-17491美元),校正患者与医院特征后仍显著。
- 术后神经认知障碍患者住院时间更长(5.91天 vs 4.29天),出院回家比例更低(22.1% vs 39.2%)。
- 术后神经认知障碍患者1年死亡率10.2%,高于无诊断者的4.4%。
- 作者认为鉴于费用负担之大,术后神经认知障碍是风险干预和价值医疗的潜在靶点。
适用人群与场景
- 2013年1月至2016年12月间在4285家提交医保按服务付费索赔的医院接受住院手术的65岁及以上医保患者。
- 纳入标准:住院 admission 与手术操作相关、索引入院前无术后神经认知障碍、未接受透析且未同时参加医疗补助。
- 排除:索引入院前已有术后神经认知障碍诊断、正在透析或同时参加医疗补助的患者。
诊断标准与关键阈值
- 术后神经认知障碍定义:索引手术出院后1年内出现国际疾病分类第九版或第十版编码的谵妄、轻度认知障碍或痴呆诊断。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用2013年1月至2016年12月4285家医院的医保按服务付费索赔数据,纳入2380473例患者(平均[SD]年龄75.36[7.31]岁;女性1336736例[56.1%])。
- 术后神经认知障碍诊断44974例(1.9%);多数为白人(2142157例[90.0%])、骨科手术(1523782例[64.0%])、城市医疗中心(2179893例[91.6%])、私立非营利医院(1798749例[75.6%])。
- 术后神经认知障碍患者 vs 无诊断者:住院时间5.91[6.01]天 vs 4.29[4.18]天(P<.001);出院回家9947例[22.1%] vs 914925例[39.2%](P<.001);1年死亡率4580例[10.2%] vs 103767例[4.4%](P<.001)。
- 校正患者与医院特征后,索引手术后1年内出现术后神经认知障碍与术后1年费用增加17275美元(95%CI 17058-17491美元)相关(P<.001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,鉴于费用负担之大,术后神经认知障碍是风险干预和价值医疗的潜在靶点。
- 研究显示术后神经认知障碍患者住院时间更长、出院回家比例更低、1年死亡率更高、1年费用更高,提示该人群需要关注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Postoperative neurocognitive disorders (PNDs) after surgical procedures are common and may be associated with increased health care expenditures.
OBJECTIVE: To quantify the economic burden associated with a PND diagnosis in 1 year following surgical treatment among older patients in the United States.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used claims data from the Bundled Payments for Care Improvement Advanced Model from 4285 hospitals that submitted Medicare Fee-for-service (FFS) claims between January 2013 and December 2016. All Medicare patients aged 65 years or older who underwent an inpatient hospital admission associated with a surgical procedure, did not experience a PND before index admission, and were not undergoing dialysis or concurrently enrolled in Medicaid were included. Data were analyzed from October 2019 and May 2020.
EXPOSURES: PND, defined as an International Classification of Diseases, Ninth or Tenth Revision, diagnosis of delirium, mild cognitive impairment, or dementia within 1 year of discharge from the index surgical admission.
MAIN OUTCOMES AND MEASURES: The primary outcome was total inflation-adjusted Medicare postacute care payments within 1 year after the index surgical procedure.
RESULTS: A total of 2 380 473 patients (mean [SD] age, 75.36 (7.31) years; 1 336 736 [56.1%] women) who underwent surgical procedures were included, of whom 44 974 patients (1.9%) were diagnosed with a PND. Among all patients, most were White (2 142 157 patients [90.0%]), presenting for orthopedic surgery (1 523 782 patients [64.0%]) in urban medical centers (2 179 893 patients [91.6%]) that were private nonprofits (1 798 749 patients [75.6%]). Patients with a PND, compared with those without a PND, experienced a significantly longer hospital length of stay (mean [SD], 5.91 [6.01] days vs 4.29 [4.18] days; P < .001), were less likely to be discharged home (9947 patients [22.1%] vs 914 925 patients [39.2%]; P < .001), and had a higher incidence of mortality at 1 year after treatment (4580 patients [10.2%] vs 103 767 patients [4.4%]; P < .001). After adjusting for patient and hospital characteristics, the presence of a PND within 1 year of the index procedure was associated with an increase of $17 275 (95% CI, $17 058-$17 491) in cost in the 1-year postadmission period (P < .001).
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that among older Medicare patients undergoing surgical treatment, a diagnosis of a PND was associated with an increase in health care costs for up to 1 year following the surgical procedure. Given the magnitude of this cost burden, PNDs represent an appealing target for risk mitigation and improvement in value-based health care.
参考来源
- Boone MD, Sites B, von Recklinghausen FM, et al. Economic Burden of Postoperative Neurocognitive Disorders Among US Medicare Patients. JAMA Netw Open. 2020. PMID: 32735336. doi:10.1001/jamanetworkopen.2020.8931
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。